FGF9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer

被引:0
|
作者
Mizukami, Takuro [1 ]
Togashi, Yosuke [2 ]
Banno, Eri [2 ]
Terashima, Masato [2 ]
de Velasco, Marco A. [2 ]
Sakai, Kazuko [2 ]
Fujita, Yoshihiko [2 ]
Tomida, Shuta [2 ]
Nakajima, Takako Eguchi [1 ]
Boku, Narikazu [1 ]
Nishio, Kazuto [2 ]
机构
[1] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan
[2] Kinki Univ, Fac Med, Osaka, Japan
关键词
D O I
10.1158/1538-7445.AM2015-5456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5456
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Fibroblast growth factor 9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer
    Mizukami, T.
    Togashi, Y.
    Banno, E.
    Terashima, M.
    De Velasco, M. A.
    Sakai, K.
    Hayashi, H.
    Fujita, Y.
    Tomida, S.
    Nakajima, T. Eguchi
    Boku, N.
    Ito, A.
    Nakagawa, K.
    Nishio, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S46 - S46
  • [2] Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies
    Mizukami, Takuro
    Togashi, Yosuke
    Naruki, Saeko
    Banno, Eri
    Terashima, Masato
    de Velasco, Marco A.
    Sakai, Kazuko
    Yoneshige, Azusa
    Hayashi, Hidetoshi
    Fujita, Yoshihiko
    Tomida, Shuta
    Nakajima, Takako Eguchi
    Fujino, Takashi
    Boku, Narikazu
    Ito, Akihiko
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    MOLECULAR CARCINOGENESIS, 2017, 56 (01) : 106 - 117
  • [3] Amplification of MET gene in anti-EGFR resistant colorectal cancer
    Bond, Theo
    PHARMACOGENOMICS, 2013, 14 (11) : 1249 - 1249
  • [4] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
    Zhao, Ben
    Wang, Lu
    Qiu, Hong
    Zhang, Mingsheng
    Sun, Li
    Peng, Ping
    Yu, Qianqian
    Yuan, Xianglin
    ONCOTARGET, 2017, 8 (03) : 3980 - 4000
  • [5] Markers of resistance to anti-EGFR therapy in colorectal cancer
    Shaib, Walid
    Mahajan, Reena
    El-Rayes, Bassel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 308 - 318
  • [6] Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
    Bardelli, Alberto
    Corso, Simona
    Bertotti, Andrea
    Hobor, Sebastijan
    Valtorta, Emanuele
    Siravegna, Giulia
    Sartore-Bianchi, Andrea
    Scala, Elisa
    Cassingena, Andrea
    Zecchin, Davide
    Apicella, Maria
    Migliardi, Giorgia
    Galimi, Francesco
    Lauricella, Calogero
    Zanon, Carlo
    Perera, Timothy
    Veronese, Silvio
    Corti, Giorgio
    Amatu, Alessio
    Gambacorta, Marcello
    Diaz, Luis A., Jr.
    Sausen, Mark
    Velculescu, Victor E.
    Comoglio, Paolo
    Trusolino, Livio
    Di Nicolantonio, Federica
    Giordano, Silvia
    Siena, Salvatore
    CANCER DISCOVERY, 2013, 3 (06) : 658 - 673
  • [7] Drivers of secondary resistance to anti-EGFR therapy in metastatic colorectal cancer
    Noseir, Soha Hussein
    Hahn, Stephan
    Maghnouj, Abdelouahid
    Ladigan, Swetlana
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Drivers of Secondary Resistance to Anti-Egfr Therapy in Metastatic Colorectal Cancer
    Noseir, Soha
    Hahn, Stephan
    Maghnouj, Abdelonahid
    Ladigan, Swetlana
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 219 - 219
  • [9] Optimizing Anti-EGFR Therapy in Colorectal Cancer
    Salazar, Ramon
    Ciardiello, Fortunato
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5415 - 5416
  • [10] Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
    Misale, Sandra
    Di Nicolantonio, Federica
    Sartore-Bianchi, Andrea
    Siena, Salvatore
    Bardelli, Alberto
    CANCER DISCOVERY, 2014, 4 (11) : 1269 - 1280